Overview

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This is an open-label dose-titration study in Japanese Central Diabetes Insipidus (CDI) patients designed to demonstrate the efficacy and safety of orally-disintegrating tablet of desmopressin.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Deamino Arginine Vasopressin